MetLife Declares $29.375 Semi-Annual Dividend with Strong Yield
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy MET?
Source: seekingalpha
- Dividend Declaration: MetLife has declared a semi-annual dividend of $29.375 per share, reflecting a robust forward yield of 74.76%, which underscores the company's strong cash flow and commitment to shareholder returns, likely attracting increased investor interest.
- Preferred Stock Dividends: The company also announced a quarterly dividend of $351.5625 per share on its 5.625% Series E non-cumulative preferred stock and $296.875 per share on its 4.75% Series F non-cumulative preferred stock, enhancing the attractiveness of its preferred shares.
- Floating Rate Preferred Stock: Additionally, MetLife plans to declare a quarterly dividend of $0.31501229 per share on its floating-rate Series A preferred stock, pending confirmation of financial tests expected around March 5, 2026, indicating confidence in future financial stability.
- Strategic Goals: Through its New Frontier strategy, MetLife has set a target of $25 billion in free cash flow and anticipates double-digit adjusted EPS growth, highlighting the company's long-term growth potential in the market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MET?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MET
Wall Street analysts forecast MET stock price to rise
12 Analyst Rating
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 77.310
Low
84.00
Averages
95.25
High
108.00
Current: 77.310
Low
84.00
Averages
95.25
High
108.00
About MET
MetLife, Inc. is a financial services company, providing insurance, annuities, employee benefits and asset management to individual and institutional customers. Its segments include Group Benefits; Retirement and Income Solutions (RIS); Asia; Latin America; Europe, the Middle East and Africa (EMEA); and MetLife Holdings. Group Benefits segment offers life insurance, dental, group short- and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment insurance, accident and health insurance, and vision, as well as prepaid legal plans and pet insurance. RIS segment provides funding and financing solutions that help institutional customers mitigate and manage liabilities primarily associated with their employee benefit programs using a spectrum of life and annuity-based insurance and investment products. It operates across EMEA in both developed (Western Europe) and emerging (Central and Eastern Europe, Middle East and Africa) markets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
MetLife Declares $29.375 Semi-Annual Dividend with Strong Yield
- Dividend Declaration: MetLife has declared a semi-annual dividend of $29.375 per share, reflecting a robust forward yield of 74.76%, which underscores the company's strong cash flow and commitment to shareholder returns, likely attracting increased investor interest.
- Preferred Stock Dividends: The company also announced a quarterly dividend of $351.5625 per share on its 5.625% Series E non-cumulative preferred stock and $296.875 per share on its 4.75% Series F non-cumulative preferred stock, enhancing the attractiveness of its preferred shares.
- Floating Rate Preferred Stock: Additionally, MetLife plans to declare a quarterly dividend of $0.31501229 per share on its floating-rate Series A preferred stock, pending confirmation of financial tests expected around March 5, 2026, indicating confidence in future financial stability.
- Strategic Goals: Through its New Frontier strategy, MetLife has set a target of $25 billion in free cash flow and anticipates double-digit adjusted EPS growth, highlighting the company's long-term growth potential in the market.
See More
MetLife Q4 2025 Earnings Call Highlights
- Strategic Progress: MetLife reported approximately $600 million in new adjusted premiums and revenues in 2025, reflecting a 10% year-over-year growth in its Group Benefits business, which strengthens its competitive position in a challenging market.
- Record Pension Risk Transfer Sales: The company achieved over $14 billion in pension risk transfer sales in 2025, marking significant growth in asset management, with year-end assets under management reaching $742 billion, highlighting strategic success in investment management.
- Shareholder Returns and Investments: MetLife returned about $2.9 billion to shareholders through stock repurchases and $1.5 billion in dividends in 2025, demonstrating its commitment to shareholder value while also investing approximately $1.2 billion in acquisitions and business development.
- Future Outlook and Targets: Management expects double-digit adjusted EPS growth in 2026, with adjusted ROE projected between 15% and 17%, indicating sustained growth potential and an enhanced market leadership position in the coming years.
See More
MetLife Reports Increased Fourth Quarter Profits Driven by Investment Returns
- Investment Income Growth: MetLife's net investment income reached $5.92 billion in Q4 2025, up from $5.41 billion a year earlier, driven by strong market performance following the Federal Reserve's rate cuts, thereby enhancing the company's overall profitability.
- Premium Revenue Surge: The company's adjusted premiums, fees, and other revenues rose by 29% to $18.61 billion in the quarter, reflecting robust consumer spending trends and disciplined premium pricing by insurers, which further fueled demand for policies.
- Increased Adjusted Earnings: MetLife reported adjusted earnings available to common shareholders of $1.65 billion, or $2.49 per share, significantly up from $1.46 billion and $2.09 per share a year prior, indicating a sustained improvement in profitability.
- Underperformance in Market: Despite strong performance in Q4 2025, the company's shares fell by 3.6% over the year, underperforming the broader market, reflecting concerns about its future growth potential.
See More
MetLife Q4 2025 Earnings Exceed Expectations
- Earnings Growth: MetLife reported an adjusted EPS of $2.58 for Q4 2025, surpassing the $2.34 analyst estimate and up 24% from $2.08 in Q4 2024, indicating a significant improvement in profitability.
- Revenue Analysis: Total revenue reached $23.8 billion, falling short of the $31.6 billion consensus but increasing 27% from $18.7 billion year-over-year, reflecting the company's efforts in diversifying income streams, particularly in Group Benefits and Retirement Solutions.
- Investment Income Improvement: Adjusted net investment income rose to $5.58 billion in Q3 2025, up from $5.30 billion in Q4 2024, demonstrating the company's effectiveness in investment management and market adaptability.
- Segment Performance: Group Benefits grew by 12% year-over-year, Retirement and Income Solutions by 18%, while Europe, the Middle East, and Africa surged by 64%, showcasing MetLife's strong performance and successful strategic positioning in global markets.
See More
MetLife Reports Decline in Q4 Profit
- Profit Decline: MetLife's Q4 net profit fell to $778 million, or $1.17 per share, down from $1.239 billion and $1.78 per share last year, indicating significant earnings pressure on the company.
- Adjusted Earnings: Excluding items, the company reported adjusted earnings of $1.709 billion, or $2.58 per share, showing some resilience in profitability despite the overall profit decline.
- Revenue Growth: The company's revenue rose 27.6% year-over-year to $23.814 billion from $18.666 billion last year, indicating strong business expansion and market demand.
- Market Impact: Despite revenue growth, the profit decline may negatively affect investor confidence, particularly as the company faces intense competition and market volatility.
See More
Analysis and Outlook: A New Decline in Software Performance
Market Trends: The software market is experiencing a significant selloff, indicating a downturn in investor confidence.
Company Focus: Anthropic, a key player in the AI sector, is highlighted amidst the broader market challenges.
See More
MetLife Declares $29.375 Semi-Annual Dividend with Strong Yield
- Dividend Declaration: MetLife has declared a semi-annual dividend of $29.375 per share, reflecting a robust forward yield of 74.76%, which underscores the company's strong cash flow and commitment to shareholder returns, likely attracting increased investor interest.
- Preferred Stock Dividends: The company also announced a quarterly dividend of $351.5625 per share on its 5.625% Series E non-cumulative preferred stock and $296.875 per share on its 4.75% Series F non-cumulative preferred stock, enhancing the attractiveness of its preferred shares.
- Floating Rate Preferred Stock: Additionally, MetLife plans to declare a quarterly dividend of $0.31501229 per share on its floating-rate Series A preferred stock, pending confirmation of financial tests expected around March 5, 2026, indicating confidence in future financial stability.
- Strategic Goals: Through its New Frontier strategy, MetLife has set a target of $25 billion in free cash flow and anticipates double-digit adjusted EPS growth, highlighting the company's long-term growth potential in the market.
See More
MetLife Q4 2025 Earnings Call Highlights
- Strategic Progress: MetLife reported approximately $600 million in new adjusted premiums and revenues in 2025, reflecting a 10% year-over-year growth in its Group Benefits business, which strengthens its competitive position in a challenging market.
- Record Pension Risk Transfer Sales: The company achieved over $14 billion in pension risk transfer sales in 2025, marking significant growth in asset management, with year-end assets under management reaching $742 billion, highlighting strategic success in investment management.
- Shareholder Returns and Investments: MetLife returned about $2.9 billion to shareholders through stock repurchases and $1.5 billion in dividends in 2025, demonstrating its commitment to shareholder value while also investing approximately $1.2 billion in acquisitions and business development.
- Future Outlook and Targets: Management expects double-digit adjusted EPS growth in 2026, with adjusted ROE projected between 15% and 17%, indicating sustained growth potential and an enhanced market leadership position in the coming years.
See More
MetLife Reports Increased Fourth Quarter Profits Driven by Investment Returns
- Investment Income Growth: MetLife's net investment income reached $5.92 billion in Q4 2025, up from $5.41 billion a year earlier, driven by strong market performance following the Federal Reserve's rate cuts, thereby enhancing the company's overall profitability.
- Premium Revenue Surge: The company's adjusted premiums, fees, and other revenues rose by 29% to $18.61 billion in the quarter, reflecting robust consumer spending trends and disciplined premium pricing by insurers, which further fueled demand for policies.
- Increased Adjusted Earnings: MetLife reported adjusted earnings available to common shareholders of $1.65 billion, or $2.49 per share, significantly up from $1.46 billion and $2.09 per share a year prior, indicating a sustained improvement in profitability.
- Underperformance in Market: Despite strong performance in Q4 2025, the company's shares fell by 3.6% over the year, underperforming the broader market, reflecting concerns about its future growth potential.
See More
MetLife Q4 2025 Earnings Exceed Expectations
- Earnings Growth: MetLife reported an adjusted EPS of $2.58 for Q4 2025, surpassing the $2.34 analyst estimate and up 24% from $2.08 in Q4 2024, indicating a significant improvement in profitability.
- Revenue Analysis: Total revenue reached $23.8 billion, falling short of the $31.6 billion consensus but increasing 27% from $18.7 billion year-over-year, reflecting the company's efforts in diversifying income streams, particularly in Group Benefits and Retirement Solutions.
- Investment Income Improvement: Adjusted net investment income rose to $5.58 billion in Q3 2025, up from $5.30 billion in Q4 2024, demonstrating the company's effectiveness in investment management and market adaptability.
- Segment Performance: Group Benefits grew by 12% year-over-year, Retirement and Income Solutions by 18%, while Europe, the Middle East, and Africa surged by 64%, showcasing MetLife's strong performance and successful strategic positioning in global markets.
See More
MetLife Reports Decline in Q4 Profit
- Profit Decline: MetLife's Q4 net profit fell to $778 million, or $1.17 per share, down from $1.239 billion and $1.78 per share last year, indicating significant earnings pressure on the company.
- Adjusted Earnings: Excluding items, the company reported adjusted earnings of $1.709 billion, or $2.58 per share, showing some resilience in profitability despite the overall profit decline.
- Revenue Growth: The company's revenue rose 27.6% year-over-year to $23.814 billion from $18.666 billion last year, indicating strong business expansion and market demand.
- Market Impact: Despite revenue growth, the profit decline may negatively affect investor confidence, particularly as the company faces intense competition and market volatility.
See More
Analysis and Outlook: A New Decline in Software Performance
Market Trends: The software market is experiencing a significant selloff, indicating a downturn in investor confidence.
Company Focus: Anthropic, a key player in the AI sector, is highlighted amidst the broader market challenges.
See More
